Fidelity Investments’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Fidelity Investments's CLBT Position: Q2 2026 in Review
Fidelity Investments reduced its Cellebrite (CLBT) stake by 30% in Q2 2026, selling an estimated $33.3M and leaving 5,971,666 shares worth $87.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1281.
Fidelity Investments first reported a position in CLBT in Q1 2022 and has held it in 11 quarters since. The position peaked at $234M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Fidelity Investments held 5,971,666 shares of Cellebrite worth $87.2M as of Q2 2026.
- Fidelity Investments sold 2,517,977 Cellebrite shares in Q2 2026, an estimated $33.3M.
- Cellebrite made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1281 holding.
- Fidelity Investments first reported a position in Cellebrite in Q1 2022 and has held it in 11 quarters since.
- Fidelity Investments's Cellebrite position peaked at $234M in Q4 2024.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.